Juan-Pablo Mas is a Partner at Action Potential VC in Palo Alto, CA, focused on medical devices and health tech, and is a founding Board Member of LatinxVC. He represents APVC on the Boards of Cala Health, CVRx, Exo Imaging, Neuspera Medical, Presidio Medical, Saluda Medical, and SetPoint Medical. He was previously an investor at Lightstone Ventures and Morgenthaler Ventures, where he was a Board Observer at Ardian, Twelve, Nuvaira, Cabochon Aesthetics, and Miramar Labs. He now serves on the Oversight Committee for Stanford’s Neuroscience Institute, the Advisory Board for UCSF’s Rosenman Institute, and the Board of Gradient Denervation Technologies.
Prior to investing, Juan-Pablo led efforts in R&D and Strategy in Medtronic’s CardioVascular Division, where he was named “Medtronic Inventor of The Year.” Subsequently, he was a member of the Global Brand Strategy team at Eli Lilly. Juan-Pablo earned an MBA from the Stanford Graduate School of Business, an M.S. in Electrical Engineering from Stanford University, and a B.S. in EE from the University of Massachusetts where he played Division I Men’s Lacrosse. He is originally from Puerto Rico.